Lindbrook Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.06K | Buy |
+265
| New | +$3.06K | ﹤0.01% | 2147 |
|
|
2024
Q4 | – | Sell |
-39
| Closed | -$452 | – | 2852 |
|
|
2024
Q3 | $452 | Hold |
39
| – | – | ﹤0.01% | 2695 |
|
|
2024
Q2 | $459 | Buy |
+39
| New | +$459 | ﹤0.01% | 2627 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2771 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2807 |
|
|
2022
Q4 | – | Sell |
-42
| Closed | -$1K | – | 2932 |
|
|
2022
Q3 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 2372 |
|
|
2022
Q2 | – | Sell |
-112
| Closed | -$2K | – | 2638 |
|
|
2022
Q1 | $2K | Buy |
+112
| New | +$2K | ﹤0.01% | 2017 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$17K | – | 2151 |
|
|
2021
Q3 | $17K | Buy |
+1,000
| New | +$17K | ﹤0.01% | 803 |
|
|
2021
Q2 | – | Sell |
-1,800
| Closed | -$46K | – | 1959 |
|
|
2021
Q1 | $46K | Buy |
+1,800
| New | +$46K | 0.01% | 479 |
|
|
2019
Q4 | – | Sell |
-1,250
| Closed | -$15K | – | 1529 |
|
|
2019
Q3 | $15K | Buy |
+1,250
| New | +$15K | 0.01% | 789 |
|
|
2019
Q1 | – | Sell |
-300
| Closed | -$5K | – | 1452 |
|
|
2018
Q4 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 1007 |
|